Chronic rhinosinusitis is inflammation of the sinuses and nasal passages that lasts at least 12 weeks. It causes ongoing symptoms, such as stuffy nose and facial pain or pressure. Although the ...

Longitudinal evaluation of SNOT-22 can distinguish patients with chronic rhinosinusitis with nasal polyps who respond quickly ...

A new CT-scan-based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis. "This allows for early prediction of disease ...

Tezepelumab (Tezspire) has shown significant clinical benefits in adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP), including marked reductions in nasal congestion and polyp ...

Blood basophils among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) may indicate the degree of inflammation, according to findings published in the European Archives of ...

About LYR-210 LYR-210 is an investigational product candidate for the treatment of chronic rhinosinusitis (CRS) in patients who have failed current therapies and require further intervention.

The purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with chronic rhinosinusitis with nasal polyps treated with intranasal corticosteroids. The ...

New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthma Lunsekimig now targeting chronic rhinosinusitis and COPD in addition to asthma Itepekimab expanding into chronic ...

New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab advance into chronic rhinosinusitis, chronic obstructive pulmonary disease, and ...